Guadalupe Oñate

7PUBLICATIONS
42CO-AUTHORS
Medical mycologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Rabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng

|May 14, 2025
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

Carlos Jimenez-Vicente, Aina Cardus, Sandra Castaño-Diez

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|Nov 09, 2024
Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome.

Jonas El Bachouti, Anna Domínguez-Guasch, Yolanda Arce

|May 05, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Guadalupe Oñate, Marta Pratcorona, Ana Garrido

|Dec 15, 2021
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.

Alex Bataller, Ana Garrido, Francesca Guijarro

Pageof 2

Frequent Collaborators

4 joint publications

Jordi Esteve

3 joint publications

Francisca Guijarro

3 joint publications

Antònia Sampol

2 joint publications

Alex Bataller